Infection surveillance software is the fastest growing segment fueling the growth of Infection Surveillance Solutions Market
The global Infection Surveillance Solutions Market is estimated to be valued at US$ 683.8 Mn in 2023 and is expected to exhibit a CAGR of 14 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Infection surveillance solutions enable effective tracking and monitoring of infections in healthcare facilities. These solutions help identify infection sources, analyze trends, and control the spread of infections.
Market key trends: One of the key trends driving the market growth is increasing healthcare expenditure. Rising healthcare expenditure has encouraged hospitals and other healthcare facilities to invest in advanced infection surveillance solutions to deliver better patient care and curb hospital-acquired infections. These solutions not only help reduce preventable infections but also decrease unnecessary antibiotic use and cut costs associated with additional treatment. For instance, effective infection surveillance prevented around $340 million in costs associated with Methicillin-resistant Staphylococcus aureus (MRSA) infections alone in the U.S. in 2018.
Segment Analysis
Content:
The infection surveillance solutions market is segmented by product & services, end user, and geography. Within products & services, software segment dominates the market owing to rising demand for data integration & information management capabilities of infection surveillance software. Software accounts for around 60% of the total market share.
Key Takeaways
Market size: The global Infection Surveillance Solutions Market is expected to witness high growth, exhibiting a CAGR of 14.% over the forecast period, due to increasing prevalence of hospital acquired infections and rising need for early detection of healthcare associated infections.
Regional analysis: North America dominates the infection surveillance solutions market with a share of over 35%, owing to stringent regulatory guidelines and rising government initiatives in the region. Asia Pacific exhibits the fastest growth due to growing healthcare expenditure and booming medical tourism in the region.
Key players: Key players operating in the Infection Surveillance Solutions Market are Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences and Premier.

Comments
Post a Comment